학술논문

The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib
Document Type
Article
Source
In: British Journal of Haematology. (British Journal of Haematology, January 2024, 204(1):191-205)
Subject
Language
English
ISSN
13652141
00071048